Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Elicio Therapeutics, Inc. (ELTX) had Pre-Tax Income of $-11.82M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-11.82M |
|
-- |
|
-- |
|
$10.60M |
|
$-10.60M |
|
$-1.22M |
|
|
Pre-Tax Income |
$-11.82M |
$-11.82M |
|
$-11.82M |
|
$-11.82M |
|
$-11.82M |
|
$-11.82M |
|
$-10.60M |
|
$-10.24M |
|
18.21M |
|
18.21M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$16.20M |
|
$0.25M |
|
$6.49M |
|
$22.69M |
|
$7.23M |
|
$9.47M |
|
$16.90M |
|
$24.13M |
|
$-1.44M |
|
$-1.44M |
|
$-1.44M |
|
18.64M |
|
| Cash Flow Statement Financials | |
$-11.64M |
|
-- |
|
$8.03M |
|
$19.27M |
|
$15.65M |
|
$-3.61M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
1.18 |
|
-6.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
822.76% |
|
822.76% |
|
-52.11% |
|
-147.09% |
|
$-0.08 |
|
$-0.64 |
|
$-0.64 |
|